Back
Xtacy Therapeutics Vs. Monopar Therapeutics Industry Stock Comparison
Sell
17
XTCY.CX
Xtacy Therapeutics
Last Price:
0.02
Seasonality Move:
-17.84%
Buy
65
MNPR
Monopar Therapeutics
Last Price:
34.14
Seasonality Move:
7.43%
Sell
17
Xtacy Therapeutics (XTCY.CX)
is a Sell
Is Xtacy Therapeutics a Buy, Sell or Hold?
- The current Xtacy Therapeutics [XTCY.CX] share price is $0.02. The Score for XTCY.CX is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
- XTCY.CX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
65
Monopar Therapeutics (MNPR)
is a Buy
Is Monopar Therapeutics a Buy, Sell or Hold?
- The current Monopar Therapeutics [MNPR] share price is $32.66. The Score for MNPR is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
- MNPR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
XTCY.CX Stock Price Chart
What is Xtacy Therapeutics's stock price today?
-
The Xtacy Therapeutics share price today is $0.02
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and XTCY.CX is experiencing slight buying pressure.
MNPR Stock Price Chart
What is Monopar Therapeutics's stock price today?
-
The Monopar Therapeutics share price today is $32.66
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MNPR is experiencing buying pressure, which is a positive indicator for future bullish movement.
XTCY.CX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0 | Sell |
| Relative Strength Index (14 RSI): | 34.43 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.02 - 0.02) | Sell |
| Bollinger Bands (100): | (0.02 - 0.04) | Sell |
MNPR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.46 | Buy |
| Relative Strength Index (14 RSI): | 93.57 | Buy |
| Chaikin Money Flow: | 12436621 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.85 - 11.69) | Buy |
| Bollinger Bands (100): | (0.99 - 7.11) | Buy |
XTCY.CX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.02 | Sell |
| 20-day SMA: | 0.02 | Sell |
| 50-day SMA: | 0.03 | Sell |
| 200-day SMA: | 0.04 | Sell |
| 8-day EMA: | 0.02 | Sell |
| 20-day EMA: | 0.02 | Sell |
| 50-day EMA: | 0.03 | Sell |
| 200-day EMA: | 0.04 | Sell |
MNPR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.64 | Buy |
| 20-day SMA: | 6.69 | Buy |
| 50-day SMA: | 4.51 | Buy |
| 200-day SMA: | 3.61 | Buy |
| 8-day EMA: | 11.25 | Buy |
| 20-day EMA: | 7.63 | Buy |
| 50-day EMA: | 5.48 | Buy |
| 200-day EMA: | 4.09 | Buy |
Xtacy Therapeutics Earnings Growth & XTCY.CX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Monopar Therapeutics Earnings Growth & MNPR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.34 per share, and a decrease next year of $0.21 per share.
Xtacy Therapeutics Technical Analysis
| Oct 9 | Oct 10 | Oct 11 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 09 | 10 | 11 | 15 | 16 | 18 | 21 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Monopar Therapeutics Technical Analysis
| Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 10 | 11 | 14 | 15 | 16 | 18 | 21 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||